Does the donor risk index and MELD score influence early recurrence of hepatitis C following transplantation.

被引:0
作者
Sinan, Abdul-Hamid [1 ]
Wong, Karen [1 ]
McAlister, Vivian [1 ]
Quan, Douglas [1 ]
Levstik, Mark [1 ]
Alqutub, Adel [1 ]
Alhamoudi, Waleed [1 ]
Eldeen, Firas Zaher [1 ]
Wall, William [1 ]
Marotta, Paul [1 ]
机构
[1] London Hlth Sci, Multi Organ Transplant Program, London, ON, Canada
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
571
引用
收藏
页码:296 / 297
页数:2
相关论文
共 50 条
[41]   Donor Risk Index for Intestinal & Multi-Visceral Transplantation. [J].
Zeng, G. ;
Chen, M. ;
Zhao, X. ;
Landsittel, D. ;
Sogawa, H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 :501-501
[42]   Treatment of hepatitis B and C following liver transplantation. [J].
Sponseller C.A. ;
Ramrakhiani S. .
Current Gastroenterology Reports, 2002, 4 (1) :52-62
[43]   Hepatitis C recurrence following liver transplantation: Does histologic severity of inflammation in the explant coorelate with recurrence? [J].
Gaglio, PJ ;
Jakab, S ;
Novogrudsky, A ;
Emond, JC ;
Brown, RS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 :360-360
[44]   Role of Donor HLA-C Genotype in Hepatitis-C Recurrence Following Liver Transplantation [J].
Kubal, Chandrashekhar A. ;
Mangus, Richard S. ;
Zheng, Dai Qi ;
Fridell, Jonathan A. ;
Vianna, Rodrigo M. ;
Higgins, Nancy ;
Lobashevsky, Andrew ;
Tector, Joseph A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 :69-70
[45]   Hepatitis C infection confers increased risk of immunologic failure following renal transplantation. [J].
Sotsky, T ;
Polyak, MMR ;
Riggio, R ;
Stubenbord, WT ;
Kapur, S ;
Serur, D ;
Billman, R ;
Balog, D ;
Kinkhabwala, M .
TRANSPLANTATION, 1999, 67 (09) :S577-S577
[46]   ECONOMIC IMPACT OF RECIPIENT MELD SCORE, BUT NOT DONOR RISK INDEX ON HOSPITAL UTILIZATION. [J].
Jatoi, Mashal A. ;
Douglas, David D. ;
Byrne, Thomas J. ;
Carey, Elizabeth J. ;
Harrison, M. E. ;
Mekeel, Kristin L. ;
Moss, Adyr A. ;
Rakela, Jorge ;
Reddy, Kunam S. ;
Vargas, Hugo E. ;
Mulligan, David C. .
LIVER TRANSPLANTATION, 2008, 14 (07) :S218-S219
[47]   MELD (model for end-stage liver disease) score does not predict patient or graft survival after living donor liver transplantation. [J].
Trotter, JF ;
Bak, T ;
Wachs, M ;
Kugelmas, M ;
Everson, GT ;
Kam, I .
HEPATOLOGY, 2002, 36 (04) :306A-306A
[48]   PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE AFTER ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE FOLLOWING LIVER TRANSPLANTATION. [J].
Cescon, Matteo ;
Grazi, Gian Luca ;
Cucchetti, Alessandro ;
Ravaioli, Matteo ;
Ercolani, Giorgio ;
Vivarelli, Marco ;
Morelli, Maria Cristina ;
Andreone, Piero ;
Tame, Maria Rosa ;
Sama, Claudia ;
Piscaglia, Fabio ;
Ballardini, Giorgio ;
Pinna, Antonio Daniele .
LIVER TRANSPLANTATION, 2008, 14 (07) :S223-S223
[49]   Early recurrence but successful treatment of hepatitis C in a completely immunosuppression-free environment after living-donor syngeneic liver transplantation. [J].
Yoshizawa, A ;
Fujimoto, Y ;
Koshiba, T ;
Pirenne, J ;
Ogura, Y ;
Kozaki, K ;
Kasahara, M ;
Ueda, M ;
Takada, Y ;
Tanaka, K .
LIVER TRANSPLANTATION, 2004, 10 (06) :C63-C63
[50]   Impact of the model for end-stage liver disease (MELD) score and donor risk index (DRI) on graft survival following liver transplantation with older grafts [J].
Hernandez-Alejandro, Roberto ;
Wall, William J. ;
Quan, Douglas ;
Paul, Marotta J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 :540-540